Evaluation of two Japanese regulatory actions using medical information databases: a ‘Dear Doctor’ letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel-Reference-Cited by-同舟云学术

Evaluation of two Japanese regulatory actions using medical information databases: a ‘Dear Doctor’ letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel

Published:2014-03-24 Issue:4 Volume:39 Page:361-367
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Hanatani T.¹²,Sai K.¹,Tohkin M.²,Segawa K.¹,Antoku Y.³,Nakashima N.³,Yokoi H.⁴,Ohe K.⁵,Kimura M.⁶,Hori K.⁷,Kawakami J.⁷,Saito Y.¹

Affiliation:

1. Division of Medicinal Safety Science; National Institute of Health Sciences; Tokyo Japan

2. Department of Regulatory Science; Graduate School of Pharmaceutical Sciences; Nagoya City University; Aichi Japan

3. Medical Information Center; Kyushu University Hospital; Fukuoka Japan

4. Department of Medical Informatics; Kagawa University Hospital; Kagawa Japan

5. Department of Medical Informatics and Economics; Division of Social Medicine; Graduate School of Medicine; The University of Tokyo; Tokyo Japan

6. Department of Medical Informatics; Hamamatsu University School of Medicine; Shizuoka Japan

7. Department of Hospital Pharmacy; Hamamatsu University School of Medicine; Shizuoka Japan

Funder

Program for the Promotion of Studies in Health Science of the Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12153/fullpdf

Reference37 articles.

2. Impact of safety-related regulatory action on clinical practice: a systematic review;Piening;Drug Saf,2012

3. Contraindicated use of cisapride: impact of food and drug administration regulatory action;Smalley;JAMA,2000

4. Drug labeling revisions-guaranteed to fail?;Woosley;JAMA,2000

5. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic;Ward;J Antimicrob Chemother,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Japan—National Insurance Claims Database (NDB);Databases for Pharmacoepidemiological Research;2021

2. Dual renin‐angiotensin‐aldosterone blockade: Implementation of published research and Dear Doctor letters in ambulatory care: A retrospective observational study using prescription data;Pharmacoepidemiology and Drug Safety;2020-03-11

3. Do drug‐related safety warnings have the expected impact on drug therapy? A systematic review;Pharmacoepidemiology and Drug Safety;2020-02-11

4. Evaluating the impact of regulatory action on denosumab‐induced hypocalcaemia in Japan;Journal of Clinical Pharmacy and Therapeutics;2019-07-07

5. Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations;British Journal of Clinical Pharmacology;2017-12-20